Biosimilars: An overview of emerging laws: A Global Study

-15% su kodu: ENG15
75,74 
Įprasta kaina: 89,10 
-15% su kodu: ENG15
Kupono kodas: ENG15
Akcija baigiasi: 2025-03-03
-15% su kodu: ENG15
75,74 
Įprasta kaina: 89,10 
-15% su kodu: ENG15
Kupono kodas: ENG15
Akcija baigiasi: 2025-03-03
-15% su kodu: ENG15
2025-02-28 89.1000 InStock
Nemokamas pristatymas į paštomatus per 11-15 darbo dienų užsakymams nuo 10,00 

Knygos aprašymas

Biosimilars have been a buzz word in pharmaceutical industry now-a-days due to melting of generic products and growth of biological in terms of market capture and efficiency. Also the biological products are more technology driven than the chemical products. Due to more novelty and technology there is a strong need of biosimilar regulations. Keeping in view to this, most of all the regulatory authorities have formed the biosimilar regulations leaded by US FDA and followed by INDIAN, Canadian, Japanese, Chinese, Korean and Singapore regulatory authorities. The stringent of all are USFDA regulations followed by Health Canada.

Informacija

Autorius: Kandarp N. Trivedi, Marmik V. Chaudhari, Bhuvan P. Raval,
Leidėjas: LAP LAMBERT Academic Publishing
Išleidimo metai: 2013
Knygos puslapių skaičius: 156
ISBN-10: 3659455601
ISBN-13: 9783659455605
Formatas: 220 x 150 x 10 mm. Knyga minkštu viršeliu
Kalba: Anglų

Pirkėjų atsiliepimai

Parašykite atsiliepimą apie „Biosimilars: An overview of emerging laws: A Global Study“

Būtina įvertinti prekę

Goodreads reviews for „Biosimilars: An overview of emerging laws: A Global Study“